Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment Number of Authors: 1272022 (English)In: European Respiratory Journal, ISSN 0903-1936, E-ISSN 1399-3003, Vol. 59, no 4, p. 2200166-, article id 2200166Article in journal, Editorial material (Other academic) Published

Place, publisher, year, edition, pages

European Respiratory Society (ERS) , 2022. Vol. 59, no 4, p. 2200166-, article id 2200166

National Category

Respiratory Medicine and Allergy Pharmacology and Toxicology

Identifiers

URN: urn:nbn:se:kth:diva-314872DOI: 10.1183/13993003.00166-2022ISI: 000810421500024PubMedID: 35422426Scopus ID: 2-s2.0-85129331780OAI: oai:DiVA.org:kth-314872DiVA, id: diva2:1676961

Note

QC 20230612

Available from: 2022-06-27 Created: 2022-06-27 Last updated: 2023-06-12Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Lyander, Anna

Search in DiVA

By author/editor

Lyander, Anna

By organisation

Gene TechnologyScience for Life Laboratory, SciLifeLab

In the same journal

European Respiratory Journal

On the subject

Respiratory Medicine and AllergyPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle ScholarTotal: 38 hits